Eramed Pharmaceuticals Private Limited
About Eramed Pharmaceuticals Private Limited
Data last updated:
Eramed Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 18 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52590DL2015PTC284183. Its GSTIN is 09AAECE0323M1ZP (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pawan Kumar Pandey and Meenakshi Pandey.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Office No.3 Plot No.34 Kh. No 13/22/2 Goela Khurd, New Delhi, Delhi, India – 110071.
As per the financials filed for FY 2020, the company reported a revenue of ₹13.92 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹5,763 (net margin 0.4%) and EBITDA of ₹78,658 (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 114% over three years.
As per MCA filings, the company has open charges of ₹2 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Eramed Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressOffice No.3 Plot No.34 Kh. No 13/22/2 Goela Khurd, New Delhi, Delhi, India – 110071
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Eramed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eramed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Eramed Pharmaceuticals Private Limited, buy the company report.
Financials of Eramed Pharmaceuticals Private Limited
FY 2020 filings availableEramed Pharmaceuticals Private Limited reported revenue of ₹13.92 Lakh (up 3% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 114% over three years, including 3% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78,658 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,763 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eramed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eramed Pharmaceuticals Private Limited
Eramed Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Kumar Pandey | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Meenakshi Pandey | Director | 18 Aug 2015 | 11 Years 2 Months | Current |
Auditor
Eramed Pharmaceuticals Private Limited is audited by PUSHKAR GUPTA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PUSHKAR GUPTA | FY 2017 | 525071 |
Shareholding
The shareholding of Eramed Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Eramed Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Mar 2018 | 100174532 | Others | ₹2 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Eramed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eramed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eramed Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECE0323M1ZP | Uttar Pradesh | Active | 01 Jul 2020 |
To see the full GST registrations and return filing status of Eramed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Eramed Pharmaceuticals Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Binita Singh ceased to be Director on 21 Dec 2016.
Frequently asked questions
Eramed Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 18 August 2015 (11+ years old) and is registered under CIN U52590DL2015PTC284183.
Eramed Pharmaceuticals has 2 current directors:
- Pawan Kumar Pandey - Director
- Meenakshi Pandey - Director
The latest financial statements of Eramed Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Eramed Pharmaceuticals is 09AAECE0323M1ZP, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Eramed Pharmaceuticals is U52590DL2015PTC284183. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eramed Pharmaceuticals was incorporated on 18 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Binita Singh ceased to be Director on 21 Dec 2016. Pawan Kumar Pandey was appointed as Director on 21 Dec 2016. Meenakshi Pandey was appointed as Director on 18 Aug 2015.
The registered office of Eramed Pharmaceuticals is at Office No.3 Plot No.34 Kh. No 13222 Goela Khurd, New Delhi, Delhi, India – 110071.
Eramed Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Eramed Pharmaceuticals has open charges of ₹2 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
